Manipal Health Enterprises Limited
- ISIN
- INE459N01021
- Instrument key
- NSE_EQ|INE459N01021
as of 21/11/2026, 3:15:23 pm
- Open
- ₹690.00
- Day high
- ₹716.60
- Day low
- ₹686.10
- Prev. close
- ₹696.45
- Volume
- 11.62 L
- VWAP
- ₹708.21
02/Price history
Price chart
1 year · daily candles. Hover the chart for the OHLC of any candle; the table below holds the same data row by row.
- Change · 1Y
- +5.29%666.95 → 702.20
- Period high
- ₹815.0028/8/2026
- Period low
- ₹597.0023/10/2026
- From high
- -13.84%+17.62% from low
- Avg volume
- 20.61 L15.46 Cr total
- Volatility · ann.
- 36.4%75 candles · 37 up / 38 down
Candle data75 rows of open, high, low, close and volumeShowHide
| 20 Nov 2026 | 690.00 | 716.60 | 686.10 | 702.20 | +1.77% | 30.50 | 11.62 L |
| 19 Nov 2026 | 692.70 | 699.95 | 680.00 | 696.45 | +0.54% | 19.95 | 10.98 L |
| 18 Nov 2026 | 701.00 | 706.40 | 685.00 | 688.85 | -1.73% | 21.40 | 7.01 L |
| 17 Nov 2026 | 694.00 | 721.60 | 686.95 | 701.95 | +1.15% | 34.65 | 21.09 L |
| 16 Nov 2026 | 684.00 | 698.40 | 661.10 | 691.25 | +1.06% | 37.30 | 25.86 L |
| 13 Nov 2026 | 675.20 | 693.00 | 671.15 | 681.40 | +0.92% | 21.85 | 11.96 L |
| 12 Nov 2026 | 684.50 | 684.50 | 662.80 | 676.50 | -1.17% | 21.70 | 11.47 L |
| 11 Nov 2026 | 669.90 | 690.55 | 667.55 | 677.45 | +1.13% | 23.00 | 17.16 L |
| 9 Nov 2026 | 660.00 | 678.25 | 652.10 | 665.15 | +0.78% | 26.15 | 15.54 L |
| 8 Nov 2026 | 654.45 | 659.90 | 652.60 | 658.40 | +0.60% | 7.30 | 59.9K |
Historical price and volume data · Showing 1–10 of 75
03/Valuation & returns
Key ratios vs sector
Company value benchmarked against the sector median. The ratio set is sector specific — banks report NIM, CASA and Net NPA instead of EV/EBITDA.
Price ÷ earnings per share
Worse than sector by 164%
Price ÷ book value per share
Worse than sector by 38%
Net income ÷ total assets
Worse than sector by 71%
Net income ÷ shareholders' equity
Worse than sector by 67%
EBIT ÷ capital employed
Worse than sector by 48%
Liquid assets ÷ current liabilities
Worse than sector by 57%
Enterprise value ÷ EBITDA
Worse than sector by 115%
04/Business
About the company
Sector: Healthcare
- ₹92,366 Cr
- $10.26B
reported in crore
reported in billion
Market capitalisation is reported at the sector-constituent level, not the standalone company level.
05/Profit & loss
Standalone income statement
Quarterly figures in ₹ crore. Growth marked reported is provided; margins are derived.
- Revenue · Sep 2026
- ₹1,250 Cr+14.74% vs Jun 2026
- Net profit · Sep 2026
- ₹165 Cr+42.40% vs Jun 2026
- Operating margin
- 17.6%was 13.9%
- Revenue CAGR · 4p
- 10.4%profit 8.2% · op 10.2%
| Revenue | 1,250 | 1,089 | 993 | 928 |
|---|---|---|---|---|
| Revenue growthreported | 14.7% | 9.7% | 7.0% | — |
| Operating profit | 220 | 152 | 118 | 164 |
| Operating profit growthreported | 44.6% | 28.2% | -27.8% | — |
| Operating marginderived | 17.6% | 13.9% | 11.9% | 17.7% |
| Net profit | 165 | 116 | 92 | 130 |
| Net profit growthreported | 42.4% | 25.6% | -29.2% | — |
| Net marginderived | 13.2% | 10.6% | 9.3% | 14.0% |
| EPS — basic₹/share, annual | — | — | 3.72 | — |
Figures in ₹ crore. Margin rows are computed from the reported values.
Full annual line itemsRevenue, other income, expenses, tax, EPSShowHide
| Revenue | 3,584 | 3,104 | 2,707 | 2,408 |
|---|---|---|---|---|
| Other Income | 117 | 101 | 81 | 65 |
| Total Revenue | 3,702 | 3,205 | 2,788 | 2,473 |
| Total Expenses | 3,116 | 2,556 | 2,220 | 2,047 |
| Profit Before Tax | 564 | 649 | 505 | 285 |
| Tax | 134 | 113 | 169 | 91 |
| Profit After Tax | 430 | 535 | 336 | 194 |
| EPS - Basic | 3.72 | 4.65 | 2.98 | 26.09 |
| EPS - Diluted | 3.70 | 4.65 | 2.97 | 25.94 |
This breakdown is available annually, even when the summary above is quarterly. EPS rows are per share.
06/Balance sheet
Standalone balance sheet
Only annual balance sheets are available — the quarterly filter does not apply here. Figures in ₹ crore; net worth is assets minus liabilities.
- Total assets · Mar 2026
- ₹11,591 Cr+38.49% YoY
- Total liabilities
- ₹4,267 Cr
- Net worth
- ₹7,323 Cr
- Liabilities ÷ assets
- 36.8%lower means a lighter balance sheet
| Total assets | 11,591 | 8,369 | 6,215 | 5,629 |
|---|---|---|---|---|
| Total liabilities | 4,267 | 3,155 | 2,318 | 2,254 |
| Net worthderived | 7,323 | 5,215 | 3,898 | 3,375 |
| Liabilities ÷ assetsderived | 36.8% | 37.7% | 37.3% | 40.0% |
| Asset growthderived | 38.5% | 34.7% | 10.4% | — |
Figures in ₹ crore. Stacked chart height equals total assets.
Full annual line itemsNon-current & current assets, liabilities, equity capitalShowHide
| Non-Current Assets | 9,515 | 6,875 | 4,910 | 4,722 |
|---|---|---|---|---|
| Current Assets | 2,076 | 1,495 | 1,305 | 907 |
| Total Assets | 11,591 | 8,369 | 6,215 | 5,629 |
| Current Liabilities | 1,138 | 739 | 720 | 713 |
| Net Current Asset | 938 | 756 | 585 | 194 |
| Non-Current Liabilities | 3,129 | 2,416 | 1,597 | 1,541 |
| Equity Capital | 7,323 | 5,215 | 3,898 | 3,375 |
| Total Equity & Liabilities | 11,591 | 8,369 | 6,215 | 5,629 |
Figures in ₹ crore unless the line item is per-share.
07/Cash flow
Standalone cash flow
Annual only, in ₹ crore. Negative values are outflows, so healthy companies usually show positive operating and negative investing cash flow.
- Operating · Mar 2026
- ₹953 Cr+47.94% YoY
- Investing
- -₹1,003 Cr
- Financing
- ₹23 Cr
- Free cash flow
- -₹50 Croperating + investing
| Operating activities | 953 | 644 | 624 | 616 |
|---|---|---|---|---|
| Operating changereported | 47.9% | 3.3% | 1.3% | — |
| Investing activities | -1,003 | -1,852 | -405 | -511 |
| Investing changereported | 45.8% | -357.2% | 20.8% | — |
| Financing activities | 23 | 1,107 | -19 | -97 |
| Financing changereported | -97.9% | 5816.0% | 80.0% | — |
| Net cash flowderived | -26 | -100 | 199 | 8 |
| Free cash flowoperating + investing | -50 | -1,207 | 219 | 105 |
Figures in ₹ crore.
Full annual line itemsProfit before tax through closing cash balanceShowHide
| Profit before tax | 564 | 649 | 505 | 285 |
|---|---|---|---|---|
| Income before WC changes | 929 | 891 | 804 | 679 |
| Change in Assets | -147 | -80 | -7 | -4 |
| Change in Liabilities | 284 | -12 | -19 | 68 |
| Change in WC | 137 | -92 | -26 | 64 |
| Cash flow from Operations | 953 | 644 | 624 | 616 |
| Cash flow from Investing | -1,003 | -1,852 | -405 | -511 |
| Cash flow from Financing | 23 | 1,107 | -19 | -97 |
| Total Cash Flow | -26 | -100 | 199 | 8 |
| Cash (Start of the year) | 128 | 228 | 29 | 20 |
| Cash (End of the year) | 102 | 128 | 228 | 29 |
Figures in ₹ crore unless the line item is per-share.
09/Events
Corporate actions
Dividends, bonuses, splits and rights issues. Filter by type, sort by any date, and expand a row for the full event detail.
No corporate actions on record
10/Comparison
Peers & competitors
Competitor set priced live. Filter by sector, sort any column, and expand a peer for its business description.
| APOLLOHOSPApollo Hospitals Enter. L | Healthcare Services | ₹9,200.00 | +5.29% | 14.13 L | ₹1,32,139 Cr | $14.68B | |
| MAXHEALTHMAX Healthcare INS Ltd | Healthcare Services | ₹1,081.00 | +3.88% | 95.32 L | ₹1,05,080 Cr | $11.68B | |
| ASTERDMAster DM Quality Care Ltd | Healthcare Services | ₹779.30 | +5.41% | 26.66 L | ₹67,960 Cr | $7.55B | |
| FORTISFortis Healthcare Ltd | Healthcare Services | ₹825.00 | +1.87% | 22.88 L | ₹62,284 Cr | $6.92B | |
| MEDANTAGlobal Health Limited | Healthcare Services | ₹1,480.20 | +0.13% | 2.65 L | ₹39,829 Cr | $4.43B | |
| NHNarayana Hrudayalaya Ltd. | Healthcare Services | ₹1,945.00 | +3.84% | 7.85 L | ₹39,757 Cr | $4.42B | |
| LALPATHLABDR. LAL Path Labs Ltd. | Healthcare Services | ₹1,989.00 | +1.31% | 2.65 L | ₹33,680 Cr | $3.74B | |
| KIMSKrishna Inst Of MED SCI L | Healthcare Services | ₹795.60 | +3.62% | 10.44 L | ₹33,483 Cr | $3.72B | |
| SYNGENESyngene International Ltd | Diversified | ₹451.70 | +3.28% | 25.58 L | ₹18,240 Cr | $2.03B | |
| MOLBIOMolbio Diagnostics Ltd | Healthcare | ₹1,495.50 | -2.02% | 7.01 L | ₹17,228 Cr | $1.91B |
Market cap is the sector-constituent figure reported per peer · Showing 1–10 of 10
11/Coverage
Company news
Articles published in the last seven days, paginated by the provider.
No news in the last seven days
Company news is available for a rolling one-week window.